Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.07 USD
Change Today -0.0029 / -3.97%
Volume 259.9K
STVF On Other Exchanges
As of 8:10 PM 12/1/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

5225 Carlson Road

Yuba City, CA 95993

United States

Phone: 530-231-7800


Stevia First Corp. operates as an agricultural biotechnology company in the United States. The company engages primarily in developing methods and technologies for industrial production of stevia, along with discovery and development of additional food and nutritional products. The company is developing and commercializing healthier food and nutrition products. Stevia is a zero-calorie alternative sweetener that is enabling sugar reduction within mainstream food and beverage products. The company is developing proprietary stevia processing technologies to increase its global supply, and intend to sell stevia at an industrial scale directly to multinational food, beverage, and ingredient companies. The company is also developing and using a bioinformatics platform that relies on artificial intelligence algorithms discover novel genes and gene combinations related to longevity, which can be used to develop medical interventions for common age-associated diseases. The company focuses on selling products through business-to-business arrangements or partnerships with multinational companies, although it would also seek to market certain products directly to consumers including stevia and other functional food and nutraceuticals that may be useful for prevention of diabetes and weight management. In 2014, the company initiated a research products business, which it owns and operates, and that provides a sales channel for certain research products and tools that it has developed, as well as new commercialization opportunities related to new technologies and trends that are of strategic interest to the company. The company’s commercial operations include its pursuit of sales of stevia extract to multinational food and beverage companies focused mainly on North America. The company’s sales and distribution operations provide North American stevia sales, marketing, and quality control support, and also provides a distribution channel for any food and nutrition products made internally using its bioprocessing methods. The company’s commercial operations also include a research products business, which entails commercialization of life sciences research products and tools, some of which are also used within its own research and development activities. Strategy The company’s strategy of differentiation in the nutraceutical and functional ingredient market is to provide a high level of quality and consistency in its products, a clear ability for its products to influence metabolic health, and to validate its products using clinical study practices that are comparable to those used by the pharmaceutical industry. Intellectual Property The company has obtained or applied for exclusive and worldwide rights to multiple patents and patent families, most of which have been developed internally, but also, including rights obtained through an exclusive license agreement with Vineland Research and Innovations Centre (the Vineland License). The Vineland License relates to certain methods for microbial production of steviol and steviol glycosides that are derived from a U.S. patent application titled, Compositions and methods for producing steviol and steviol glycosides. The Vineland License has an initial term of 10 years and may be renewed by the company for additional two-year terms until all licensed patents have expired, which is March 19, 2027 for U.S. Patent No. 7927851, March 20, 2027 for European Union Patent No. EP1897951B1, and March 21, 2027 for Canadian Patent No. 2580429. The company’s internally developed patents include provisional and non-provisional patent applications filed in the United States in 2013, 2014, and 2015 covering biosynthesis methods for steviol glycosides, enzyme enhancement methods, use of agricultural drones and robotic systems in agriculture, and methods for combined processing of sugar and stevia leaf extract. Research and Development During the fiscal year ended March 31, 2015, the company incurred $1,131,327 in expenses that were allocated to research and development activities. Competition The company’s major competitors for its stevia business are existing stevia producers in Japan, Korea, China and Malaysia. These competitors include Cargill, Incorporated; GLG Life Tech Corp.; Evolva Holding SA; Blue California Inc.; Corn Products International, Inc.; DSM Nutritional Products; and PureCircle Limited. Government Regulation In addition to laws and regulations enforced by the U.S. Food and Drug Administration and those related to the sale of stevia leaf or refined stevia extract as a food, beverage or ingredient, the company is also subject to regulations under the Occupational Safety and Health Act, other labor and employment laws, and other present and potential future federal, state or local laws and regulations applicable to its operations as an agricultural biotechnology company. Further, the company’s agricultural operations are subject to a range of evolving environmental laws and regulations. These laws and regulations include the Clean Air Act, the Clean Water Act, the Resource Conservation and Recovery Act, the Federal Insecticide, Fungicide and Rodenticide Act and the Comprehensive Environmental Response, Compensation and Liability Act. History The company was founded in 2007. It was incorporated under the laws of the state of Nevada in 2007. The company was formerly known as Legend Mining Inc. and changed its name to Stevia First Corp. in 2011.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STVF:US $0.07 USD -0.0029

STVF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Evolva Holding SA SFr.1.14 CHF -0.01
GLG Life Tech Corp C$0.35 CAD 0.00
Ingredion Inc $98.85 USD +0.28
PureCircle Ltd 400.00 GBp -1.00
Takeda Pharmaceutical Co Ltd ¥6,047 JPY -43.00
View Industry Companies

Industry Analysis


Industry Average

Valuation STVF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 24.8x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 21.9x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact STEVIA FIRST CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at